A better count, but a persistent dependency

Department of Energy data reviewed by GAO show isotopes with market disruptions declined from 40 in 2023 to 25 in 2025. That is 15 fewer disruptions, a 37.5% reduction.

The remaining risk is concentrated: the United States still relied on countries deemed sensitive for a majority of those 25 isotopes. GAO did not publish a single percentage in its summary, so 'majority' should not be converted into a more precise figure.

A large operation runs on case-by-case forecasting

DOE's isotope office produced, sold and distributed 265 isotopes and made more than 7,700 shipments from fiscal years 2020 through 2025, most for medical purposes. The same materials also support national security, industry and quantum research.

Despite that scale, GAO found that the office assessed market needs case by case and manually tracked interactions. It had not systematically aligned production with demand or developed timely actions for emerging shortages.

Four open actions have different clocks

DOE agreed to all four recommendations. It said a required advisory committee should hold its first meeting by December 2026, while frameworks for demand assessment and risk mitigation were targeted for October 2027.

Those commitments are milestones, not completed safeguards. The public should distinguish the nearer committee target from the later operational framework and check whether each produces measurable changes in supply resilience.

Method and limits

This newsroom recomputed the disruption decline and placed it beside the shipment and product counts to show that fewer documented disruptions do not eliminate foreign-dependency risk. GAO examined agency documents, revenue, cost, sales and shipment data and interviewed a nongeneralizable set of customers and production sites.

The record does not show that any patient missed treatment because of a specific 2025 disruption, nor does it identify every sensitive supplier in the summary. The finding concerns preparedness and market intelligence, not the safety or quality of DOE-produced isotopes.

Sources and further reading

GAO-26-108053: Managing Critical Isotopes ↗

DVIDS Oak Ridge laboratory photograph and public-domain record ↗